C07D 453/02
Containing not further condensed quinuclidine ring systems
Official title: containing not further condensed quinuclidine ring systems
C07D453/02 (Containing not further condensed quinuclidine ring systems) appears on 1,327 US grants and 1,147 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,327
- Published applications
- 1,147
- Assignees
- 556
- Inventors
- 3,558
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 4 | 0 |
| 1978 | 13 | 0 |
| 1979 | 4 | 0 |
| 1980 | 7 | 0 |
| 1981 | 1 | 0 |
| 1982 | 5 | 0 |
| 1983 | 3 | 0 |
| 1984 | 7 | 0 |
| 1985 | 7 | 0 |
| 1986 | 10 | 0 |
| 1987 | 11 | 0 |
| 1988 | 7 | 0 |
| 1989 | 17 | 0 |
| 1990 | 26 | 0 |
| 1991 | 12 | 0 |
| 1992 | 23 | 0 |
| 1993 | 46 | 0 |
| 1994 | 27 | 0 |
| 1995 | 22 | 0 |
| 1996 | 46 | 0 |
| 1997 | 42 | 0 |
| 1998 | 49 | 0 |
| 1999 | 42 | 0 |
| 2000 | 25 | 0 |
| 2001 | 30 | 1 |
| 2002 | 24 | 22 |
| 2003 | 18 | 42 |
| 2004 | 19 | 59 |
| 2005 | 24 | 75 |
| 2006 | 30 | 47 |
| 2007 | 36 | 67 |
| 2008 | 47 | 56 |
| 2009 | 40 | 61 |
| 2010 | 41 | 59 |
| 2011 | 35 | 60 |
| 2012 | 50 | 44 |
| 2013 | 57 | 52 |
| 2014 | 53 | 71 |
| 2015 | 60 | 58 |
| 2016 | 51 | 48 |
| 2017 | 51 | 46 |
| 2018 | 36 | 46 |
| 2019 | 40 | 27 |
| 2020 | 30 | 34 |
| 2021 | 17 | 27 |
| 2022 | 23 | 31 |
| 2023 | 11 | 37 |
| 2024 | 11 | 28 |
| 2025 | 17 | 17 |
| 2026 | 11 | 32 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Salt forms of sabcomeline18 Aug 2026US 12,709,611 B2Syremis Therapeutics, Ltd.
- Compounds having inhibitory activity against glucosylceramide synthase or pharmaceutically acceptable salt thereof, processes for preparing the same, and pharmaceutical compositions comprising the same7 Jul 2026US 12,673,944 B2The Green Cross Corporation
- Ionizable lipids for nucleic acid delivery26 May 2026US 12,636,368 B2Global Life Sciences Solutions Canada ULC
- Aryl pladienolides for the treatment of neoplastic disorders12 May 2026US 12,622,905 B2Eisai R&D Management Co., Ltd.
- Organic Photoredox Catalysts, Compositions, and Conversion Processes24 Sep 2026US 2026/0284647 A1Colorado State University Research Foundation
- Ionizable lipids for nucleic acid delivery17 Sep 2026US 2026/0273066 A1Global Life Sciences Solutions Canada ULC
- Bulky and small-steric-hindrance ligand and use thereof17 Sep 2026US 2026/0273518 A1Dg Hc Optical Co., Ltd
- 2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)-acetamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk510 Sep 2026US 2026/0265224 A1Agomab Spain, S.L.U.
- Melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof27 Aug 2026US 2026/0250265 A1Crinetics Pharmaceuticals, Inc.
Most cited
By later US patents
- N[.omega.,(.omega.-1)-dialkyloxy]- and N-[.omega.,(.omega.-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor740US 4,897,355 ASyntex (U.S.A.) Inc. · 1990
- N-(.omega.,(.omega.-1)-dialkyloxy)- and N-(.omega.,(.omega.-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor306US 4,946,787 ASyntex (U.S.A.) Inc. · 1990
- N-.omega.,(.omega.-1)-dialkyloxy)- and N-(.omega.,(.omega.-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor234US 5,049,386 ASyntex (U.S.A.) Inc. · 1991
- N-(.omega., (.omega.-1)-dialkyloxy)- and N-(.omega., (.omega.-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor198US 5,208,036 ASyntex (U.S.A.) Inc. · 1993
- Zirconium phosphate and method for its preparation138US 4,826,663 AEniricerche S. p. A. · 1989